Rapilysin Európska únia - slovenčina - EMA (European Medicines Agency)

rapilysin

actavis group ptc ehf - retepláza - infarkt myokardu - antitrombotické činidlá - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.

PLEUMOLYSIN Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

pleumolysin

teva czech industries s.r.o., Česká republika - Ópiové deriváty a mukolytiká - 52 - expectorantia, mucolytica